Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, a third of patients did not achieve remission or adequate response after two treatment trials, fulfilling requirements for treatment resistant depression (TRD). The present study is a secondary analysis of the STAR*D data conducted to compare the humanistic outcomes in patients with TRD and non-TRD MDD. METHODS: Patients with major depressive disorder who entered level 3 of the STAR*D were included in the TRD group, while patients who responded to treatment and entered follow-up from level 1 or 2 were included in the non-TRD group. The first visit in level 1 was used for baseline assessments. The time-point of assessments for comparison was the first visit in level 3 for TRD patients (median day: 141), and the visit closest to 141 ± 60 days from baseline for non-TRD patients. Outcomes were assessed by the 12-item Short Form Health Survey (SF12), 16-item Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q), Work and Social Adjustment Scale (WSAS), and Work Productivity and Activity Impairment scale (WPAI). Scores were compared in a linear model with adjustment for covariates including age, gender, and depression severity measured by the 17-item Hamilton Rating Scale for Depression (HDRS17) and Quick Inventory of Depressive Symptomatology (QIDS). RESULTS: A total of 2467 (TRD: 377; non-TRD: 2090) patients were studied. TRD patients were slightly older (mean age 44 vs 42 years), had a higher proportion of men (49% vs 37%, p < .0001), and baseline depression severity (HDRS17: 24.4 vs 22.0, p < .0001) vs non-TRD patients. During follow-up, TRD patients had lower health-related quality of life (HRQOL) scores on mental (30 vs 45.7) and physical components (47.7 vs 48.9) of the SF12, and lower Q-LES-Q scores (43.6 vs 63.7), greater functional and work impairments and productivity loss vs non-TRD patients (all p < 0.05). CONCLUSION: Patients with TRD had worse HRQOL, work productivity, and social functioning than the non-TRD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Patients with TRD have pronounced decreases in daily functioning and health-related quality of life, compared to non-TRD MDD patients [6]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
CUMULATIVE ILLNESS RATING SCALE
LINN, B. S., LINN, M. W., & GUREL, L. (1968) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1968.tb02103.x · Cited by 2,304
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Treatment-resistant depression: therapeutic trends, challenges, and future directions
Al-harbi (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s29716 · Cited by 796
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Reliability and validity of the SF-12 health survey among people with severe mental illness
Salyers, M. P., Bosworth, H. B., Swanson, J. W., Lamb-Pagone, J., & Osher, F. C. (2000) · Medical Care · doi:10.1097/00005650-200011000-00008 · Cited by 390
National Institute of Mental Health (NIMH)
(2008) · Encyclopedia of Global Health · doi:10.4135/9781412963855.n834 · Cited by 348
Research works printed but not linked: 1
- Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA. STAR*D: revising conventional wisdom. CNS drugs. 2009;23(8):627–47.
Cited by
Zaki, N., Chen, L., Lane, R., Doherty, T., Drevets, W. C., Morrison, R. L., Sanacora, G., Wilkinson, S. T., Popova, V., & Fu, D.-J. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01577-5 · Cited by 137
“Patients with TRD have pronounced decreases in daily functioning and health-related quality of life, compared to non-TRD MDD patients [6], underscoring the need for treatment choices with sustained efficacy and tolerability over the long-term.”
Haller, N., Senner, F., Brunoni, A. R., Padberg, F., & Palm, U. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.009 · Cited by 58
Augmentation with Atypical Antipsychotics for Treatment-Resistant Depression
Cantù, F., Ciappolino, V., Enrico, P., Moltrasio, C., Delvecchio, G., & Brambilla, P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.006 · Cited by 54
Soares, B. G., KANEVSKY, G. A., Teng, C. T., Pérez‐Esparza, R., Bonetto, G. G., Lacerda, A. L. T., Uribe, E. S., Cordoba, R., Lupo, C., Samora, A. M., et al. (2021) · Psychiatric Quarterly · doi:10.1007/s11126-021-09930-x · Cited by 55
“As expected based on previous studies [9, 10], patients with TRD demonstrated significantly greater work impairment than patients with non-TRD on most WPAI:D items.”
ResultKern, D. M., Canuso, C. M., Daly, E., Johnson, J., Fu, D., Doherty, T., Blauer-Peterson, C. J., & Cepeda, M. S. (2023) · Brain and Behavior · doi:10.1002/brb3.3171 · Cited by 53
“…had increasingly lower remission rates (remission rates of 36.8%, 30.6%, 13.7%, and 13.0% for the first, second, third, and fourth treatment steps, respectively) and higher relapse rates, highlighting the challenges in treating patients with TRD (DiBernardo et al., 2018; Rush et al., 2006).”
BackgroundInfluential
Metadata
- Authors
- DiBernardo, A., Lin, X., Zhang, Q., Xiang, J., Lu, L., Jamieson, C., Benson, C., Lee, K., Bodén, R., Brandt, L., Brenner, P., Reutfors, J., & Li, G.
- Affiliations
- Janssen Scientific Affairs (United States) (US)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Janssen (United States) (US)
- Corresponding author
- Li, Gang
- ORCID
- Venue
- BMC Psychiatry
- Published
- 2018-10-29
- Volume
- 18
- Issue
- 1
- Pages
- 352-352
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC6206859
- OpenAlex
- W2899445727
- Cited by
- 66
- References
- 35
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 14 · 2022: 12 · 2021: 5 · 2020: 8 · 2019: 4
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Janssen Research and Development (NA)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- treatment-resistant depression, major depressive disorder, humanistic outcomes, health-related quality of life, labor productivity, social functioning, work impairment, STAR*D, remission, functional disability, SF-12, Q-LES-Q, Work and Social Adjustment Scale, Work Productivity and Activity Impairment, depression severity, gender differences
- MeSH terms
- Adolescent, Adult, Aged, Major Depressive Disorder, Female, Humans, Humanism, Male, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Quality of Life, Surveys and Questionnaires, Retrospective Studies, Treatment Outcome, Diagnostic and Statistical Manual of Mental Disorders, Young Adult, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study. https://app.cochat.ai/papers/10.1186/s12888-018-1920-7
- The paper
- DiBernardo, A., Lin, X., Zhang, Q., Xiang, J., Lu, L., Jamieson, C., Benson, C., Lee, K., Bodén, R., Brandt, L., Brenner, P., Reutfors, J., & Li, G. (2018). Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study. BMC Psychiatry. https://doi.org/10.1186/s12888-018-1920-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.